Cannabis Stocks Drop After Early Surge on Limited US Marijuana Rescheduling Move
Cannabis stocks fell after hype faded: US reform helps medical marijuana only, not full market, so investors took profits.
Cannabis stocks fell after hype faded: US reform helps medical marijuana only, not full market, so investors took profits.
The Trump administration is expected to reclassify marijuana from Schedule I to Schedule III as soon as this week, easing research barriers after months of delay.
President Trump signs an executive order to shift cannabis to Schedule III, potentially expanding medical use, research, and business opportunities nationwide.
Cannabis stocks jumped after reports that President Trump may push to reclassify marijuana to Schedule III, easing restrictions and boosting industry prospects.
Cronos Group acquires CanAdelaar, the leading cannabis company in the Netherlands’ Wietexperiment, strengthening its European footprint and borderless product strategy.